Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients
- PMID: 35162068
- PMCID: PMC8834158
- DOI: 10.3390/ijerph19031047
Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients
Abstract
The Coronavirus Disease 2019 (COVID-19) outbreak caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) resulted in a worldwide pandemic of a highly infectious disease. The difficulty of dealing with COVID-19 is the broad spectrum of clinical manifestations that involves various pathophysiological mechanisms, severities, duration, and complications. This study aims to help emphasize the factors related to the persistence and duration of anosmia (loss of smell) and ageusia (loss of taste) as part of post-acute COVID-19 syndrome in Saudi COVID-19 patients via a retrospective cross-sectional design. Eight hundred and eighty-one participants were recruited between March and April 2021. Those participants were 18 years or older, recovered from the COVID-19 infection, and completed 14 days after the onset of the acute phase of the disease. Among the 881 recruited participants, 808 have submitted eligible responses and were included in data analyses. The most common persistent symptoms in post-acute COVID-19 syndrome were anosmia (33.8%) and ageusia (26.4%). The data also showed a significant association between female sex and the incidence and the persistence of anosmia and ageusia. In multivariable analysis, anosmia during the acute phase was associated with BMI, asthma and shortness of breath, while anosmia during the post-acute phase was associated with sex. Ageusia during the acute phase was associated with sex, myalgia and arthralgia, while ageusia in the post-acute phase was associated with sex.
Keywords: COVID-19; SARS-CoV-2; Saudi Arabia; ageusia; anosmia; post-acute COVID-19 syndrome.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Post-acute COVID-19 condition in Saudi Arabia: A national representative study.J Infect Public Health. 2022 May;15(5):526-532. doi: 10.1016/j.jiph.2022.03.013. Epub 2022 Mar 25. J Infect Public Health. 2022. PMID: 35429791 Free PMC article.
-
New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.Clin Microbiol Infect. 2020 Sep;26(9):1236-1241. doi: 10.1016/j.cmi.2020.05.026. Epub 2020 Jun 2. Clin Microbiol Infect. 2020. PMID: 32502645 Free PMC article.
-
Prevalence of Chemosensitive Neurological Disorders of Smell and Taste and Association with Blood Groups in SARS-CoV-2 Patients: Cross-Sectional Study.Viruses. 2023 May 30;15(6):1277. doi: 10.3390/v15061277. Viruses. 2023. PMID: 37376577 Free PMC article.
-
Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia.Int J Mol Sci. 2021 Aug 18;22(16):8912. doi: 10.3390/ijms22168912. Int J Mol Sci. 2021. PMID: 34445619 Free PMC article. Review.
-
Onset and duration of symptoms of loss of smell/taste in patients with COVID-19: A systematic review.Am J Otolaryngol. 2021 Mar-Apr;42(2):102889. doi: 10.1016/j.amjoto.2020.102889. Epub 2021 Jan 6. Am J Otolaryngol. 2021. PMID: 33445036 Free PMC article.
Cited by
-
Persistent Smell Disorders After COVID-19 Infection and Their Impact on Quality of Life.Cureus. 2024 Apr 17;16(4):e58469. doi: 10.7759/cureus.58469. eCollection 2024 Apr. Cureus. 2024. PMID: 38765373 Free PMC article.
-
The long-term effect of COVID-19 infection on olfaction and taste; a prospective analysis.Eur Arch Otorhinolaryngol. 2024 Nov;281(11):6001-6007. doi: 10.1007/s00405-024-08827-2. Epub 2024 Jul 8. Eur Arch Otorhinolaryngol. 2024. PMID: 38976065 Free PMC article.
-
Characteristics of Oral Adverse Effects following COVID-19 Vaccination and Similarities with Oral Symptoms in COVID-19 Patients: Taste and Saliva Secretory Disorders.Med Princ Pract. 2025;34(2):101-120. doi: 10.1159/000543182. Epub 2024 Dec 19. Med Princ Pract. 2025. PMID: 39701050 Free PMC article. Review.
-
COVID-19, Anosmia, and Allergies: Is There a Relationship? A Pediatric Perspective.J Clin Med. 2022 Aug 26;11(17):5019. doi: 10.3390/jcm11175019. J Clin Med. 2022. PMID: 36078947 Free PMC article.
-
Evaluation of Clinical Features and Olfactory Functions in COVID-19: A Multicentre Study.Cureus. 2023 Jun 6;15(6):e40027. doi: 10.7759/cureus.40027. eCollection 2023 Jun. Cureus. 2023. PMID: 37425551 Free PMC article.
References
-
- Weekly Operational Update on COVID-19-9 August 2021. [(accessed on 5 November 2021)]. Available online: https://www.who.int/publications/m/item/weekly-operational-update-on-COV....
-
- Lechien J.R., Chiesa-Estomba C.M., De Siati D.R., Horoi M., Le Bon S.D., Rodriguez A., Dequanter D., Blecic S., El Afia F., Distinguin L., et al. Olfactory and Gustatory Dysfunctions as a Clinical Presentation of Mild-to-Moderate Forms of the Coronavirus Disease (COVID-19): A Multicenter European Study. Eur. Arch. Otorhinolaryngol. 2020;277:2251–2261. doi: 10.1007/s00405-020-05965-1. - DOI - PMC - PubMed
-
- Brann D.H., Tsukahara T., Weinreb C., Lipovsek M., Van Den Berge K., Gong B., Chance R., Macaulay I.C., Chou H.-J., Fletcher R.B., et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci. Adv. 2020;6:eabc5801. doi: 10.1126/sciadv.abc5801. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous